292 related articles for article (PubMed ID: 32733288)
1. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
[TBL] [Abstract][Full Text] [Related]
2. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
Bonnet U; Specka M; Kanti AK; Scherbaum N
Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
Niebel A; Pragst F; Krumbiegel F; Hartwig S
Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy.
La Maida N; Di Giorgi A; Pichini S; Pellegrini M; Di Trana A; Elmo MG; Polselli GM; Casella P; Di Stefano A; Ducci G
Ther Drug Monit; 2024 Apr; 46(2):203-209. PubMed ID: 38018870
[TBL] [Abstract][Full Text] [Related]
5. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
[TBL] [Abstract][Full Text] [Related]
6. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
[TBL] [Abstract][Full Text] [Related]
7. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
Gray R; Bressington D; Hughes E; Ivanecka A
J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
[TBL] [Abstract][Full Text] [Related]
9. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening.
Heikman P; Sundström M; Pelander A; Ojanperä I
Hum Psychopharmacol; 2016 Jan; 31(1):44-52. PubMed ID: 26763789
[TBL] [Abstract][Full Text] [Related]
10. Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.
Bijlsma L; Celma A; Castiglioni S; Salgueiro-González N; Bou-Iserte L; Baz-Lomba JA; Reid MJ; Dias MJ; Lopes A; Matias J; Pastor-Alcañiz L; Radonić J; Turk Sekulic M; Shine T; van Nuijs ALN; Hernandez F; Zuccato E
Sci Total Environ; 2020 Jul; 725():138376. PubMed ID: 32298891
[TBL] [Abstract][Full Text] [Related]
11. High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients.
Scherbaum N; Seiffert F; Schifano F; Specka M; Bonnet U; Bender S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Dec; 111():110144. PubMed ID: 33091544
[TBL] [Abstract][Full Text] [Related]
12. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
[TBL] [Abstract][Full Text] [Related]
13. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
[No Abstract] [Full Text] [Related]
14. Synthetic cathinones: an evolving class of new psychoactive substances.
Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017).
Larabi IA; Fabresse N; Etting I; Nadour L; Pfau G; Raphalen JH; Philippe P; Edel Y; Alvarez JC
Drug Alcohol Depend; 2019 Nov; 204():107508. PubMed ID: 31670189
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drugs of abuse found in forensic testing of illicit drug seizures and urine samples from offenders/probationers in Hong Kong: A 3-year update.
Cheng WC; Dao KL
Forensic Sci Int; 2020 Dec; 317():110535. PubMed ID: 33075647
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
Front Psychiatry; 2021; 12():681542. PubMed ID: 33967867
[TBL] [Abstract][Full Text] [Related]
18. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
[TBL] [Abstract][Full Text] [Related]
19. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
[TBL] [Abstract][Full Text] [Related]
20. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.
Helander A; Beck O; Bäckberg M
Clin Toxicol (Phila); 2015 Jun; 53(5):446-53. PubMed ID: 25881797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]